FDA Inspection 1020135 — Blood Center (The)

Blood Center (The) — FEI 3006611631

The FDA completed an inspection of Blood Center (The) on Jun 29, 2017 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 29, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Orleans, LA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.